Preferences for follow up in long‐term survivors after cervical cancer

Ingvild Vistad; Kristina Lindemann; Anne G. Bentzen; Alv A. Dahl; Rita Steen; Cecilie Kiserud

doi:10.1111/aogs.13855

journal article Open Access Apr 15, 2020

Preferences for follow up in long‐term survivors after cervical cancer

Ingvild Vistad

Kristina Lindemann

Anne G. Bentzen Alv A. Dahl Rita Steen Cecilie Kiserud

Acta Obstetricia et Gynecologica Scandinavica Vol. 99 No. 9 pp. 1253-1259 · Wiley

View at Publisher Save 10.1111/aogs.13855

Abstract

AbstractIntroductionAn increasing number of cervical cancer survivors combined with lack of data on the efficacy of long‐term surveillance, challenges existing follow‐up models. However, before introducing new follow‐up models, cervical cancer survivors’ own views on follow up are important. We aimed to explore preferences for follow up in long‐term cervical cancer survivors and their associations with self‐reported late‐effects.Material and methodsIn 2013, we mailed 974 Norwegian long‐term cervical cancer survivors treated during 2000‐2007 a questionnaire with items covering preferences for follow up after treatment, clinical variables and validated questionnaires covering anxiety, neuroticism and depression.ResultsWe included 471 cervical cancer survivors (response rate 57%) with a median follow up of 11 years. In all, 77% had FIGO stage I disease, and 35% were attending a follow‐up program at the time of survey. Of the patients, 55% preferred more than 5 years of follow up. This was also preferred by 57% of cervical cancer survivors who were treated with conization only. In multivariable analyses, chemo‐radiotherapy or surgery with radiation and/or chemotherapy (heavy treatment) and younger age were significantly associated with a preference for more than 5 years’ follow up. Late effects were reported by more than 70% of the cervical cancer survivors who had undergone heavy treatment.ConclusionsOur study reveals the need for targeted patient education about the benefits and limitations of follow up. To meet increasing costs of cancer care, individualized follow‐up procedures adjusted to risk of recurrence and late‐effects in cervical cancer survivors are warranted.

Topics

No keywords indexed for this article. Browse by subject →

References

30

[1]

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo et al.

The Lancet 10.1016/s0140-6736(17)33326-3

[2]

The Norwegian Cancer Registry.https://www.kreftregisteret.no/en/The‐Registries/Cancer‐Statistics/. Accessed March 20 2020.

[3]

10.1111/j.1600-0412.2012.01523.x

[4]

10.1016/j.ygyno.2007.07.025

[5]

Lajer H "The value of gynecologic cancer follow‐up: evidence‐based ignorance?" Int J Gynecol Cancer (2010)

[6]

10.1016/j.clinthera.2014.11.013

[7]

10.1038/bjc.2011.315

[8]

Danish Gynecological Cancer Society.Follow‐up programme for gynecological cancers.http://www.dgcg.dk/index.php/guidelines/nye‐guidelines‐for‐opfolgning. Accessed March 20 2020.

[9]

10.1016/j.ygyno.2017.03.022

[10]

Norwegian Gynecological Cancer Society’s Guidelines 2015.https://www.legeforeningen.no/foreningsledd/fagmed/norsk‐gynekologisk‐forening/veiledere/. Accessed February 10 2020.

[11]

10.1038/sj.bjc.6601655

[12]

10.1016/j.ejso.2011.06.007

[13]

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Ales et al.

Journal of Chronic Diseases 10.1016/0021-9681(87)90171-8

[14]

Norwegian Guidelines in Gynecologic Oncology.2018.https://www.helsedirektoratet.no/retningslinjer/gynekologisk‐kreft‐handlingsprogram. Accessed March 20 2020.

[15]

10.1016/j.ygyno.2017.05.028

[16]

10.1007/s00405-011-1884-4

[17]

10.3109/01612840.2012.713082

[18]

The validity of the Hospital Anxiety and Depression Scale

Ingvar Bjelland, Alv A Dahl, Tone Tangen Haug et al.

Journal of Psychosomatic Research 10.1016/s0022-3999(01)00296-3

[19]

The PHQ-9

Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams

Journal of General Internal Medicine 10.1046/j.1525-1497.2001.016009606.x

[20]

10.1016/j.maturitas.2017.07.001

[21]

10.1111/aogs.13396

[22]

10.1016/j.radonc.2016.06.006

[23]

10.1016/j.ygyno.2006.03.050

[24]

10.1111/j.1471-0528.2007.01445.x

[25]

10.1016/s1470-2045(16)30386-2

[26]

10.1097/igc.0000000000001082

[27]

10.1002/cncr.31165

[28]

10.1097/igc.0000000000000884

[29]

10.1111/aogs.13199

[30]

10.1080/01443610802646801

Metrics

5

Citations

30

References

Details

Published: Apr 15, 2020
Vol/Issue: 99(9)
Pages: 1253-1259
License: View

Authors

I

Ingvild Vistad

Department of Obstetrics and Gynecology Sørlandet Hospital Kristiansand Kristiansand Norway; Department of Clinical Science University of Bergen Bergen Norway

K

Kristina Lindemann

Department of Gynecologic Oncology Oslo University Hospital The Norwegian Radium Hospital Oslo Norway; Faculty of Medicine Institute of Clinical Medicine University of Oslo Oslo Norway

A

Anne G. Bentzen

Department of Gynecologic Oncology University Hospital of North Norway Tromsø Norway

A

Alv A. Dahl

Faculty of Medicine Institute of Clinical Medicine University of Oslo Oslo Norway; National Advisory Unit on Late Effects after Cancer Treatment Oslo University Hospital The Norwegian Radium Hospital Oslo Norway

R

Rita Steen

Department of Clinical Service The Cancer Clinic Oslo University Hospital Oslo Norway; Department of Pain Management and Research Oslo University Hospital Oslo Norway

C

Cecilie Kiserud

National Advisory Unit on Late Effects after Cancer Treatment Oslo University Hospital The Norwegian Radium Hospital Oslo Norway

Cite This Article

Ingvild Vistad, Kristina Lindemann, Anne G. Bentzen, et al. (2020). Preferences for follow up in long‐term survivors after cervical cancer. Acta Obstetricia et Gynecologica Scandinavica, 99(9), 1253-1259. https://doi.org/10.1111/aogs.13855

Preferences for follow up in long‐term survivors after cervical cancer

You May Also Like